Synthesis of chemoreversible prodrugs of ara-C with variable time-release profiles. Biological evaluation of their apoptotic activity

Bioorganic and Medicinal Chemistry

Volumn 4, Issue 10, 1996, Pages 1585-1596

  Wipf, Peter ^a   Li, Wenjie ^a   Adeyeye, Christianah M ^b   Rusnak, James M ^c   Lazo, John S ^c  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b DUQUESNE UNIVERSITY   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYTARABINE; CYTARABINE DERIVATIVE; PRODRUG;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; DRUG SYNTHESIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; LEUKEMIA CELL; NONHUMAN;

ANIMALIA; ARA; MURINAE;

EID: 0030272288     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/0968-0896(96)00153-8     Document Type: Article

References (33)

1. 1. Carey, R. W.; Ribas-Mundo, M.; Ellison, R. R.; Glidewell, O.; Lee, S. T.; Cuttner, J.; Levy, R. N.; Silver, R.; Blom, J.; Haurani, F.; Spurr, C. L.; Harley, J. B.; Kyle, R.; Moon, J. H.; Eagan, R. T.; Holland, J. H. Cancer 1975, 36, 1560.
2. 2. Clarkson, B. D.; Dowling, M. D.; Gee, T. S.; Cunningham, I. B.; Burchenal, J. H. Cancer 1975, 36, 775.
3. 3. Bodey, G. P.; Rodriguez, V. Semin. Hematol. 1978, 15, 221.
4. 4. Plagemann, P. G.; Marz, R.; Wohlhueter, R. M. Cancer Res. 1978, 38, 978.
5. 5. Capizzi, R. L.; White, J. C.; Powell, B. L.; Perrino, F. Semin. Hematol. 1991, 28, 54.
6. 6. Rustum, Y. M.; Raymakers, R. A. Pharmacol. Ther. 1992, 56, 307.
7. 7. Wipf, P.; Li, W. Drugs Future 1994, 19, 49, and references cited therein.
8. 8. For a preliminary communication of some of the synthetic chemistry in this work, see: Wipf, P.; Li, W.; Sekhar, V. Bioorg. Med. Chem. Lett. 1991, 1, 745.
9. 9. The term chemoreversible reflects the capability of these prodrugs to spontaneously release drug without the intervention of an external agent by an intramolecular process. In contrast, bioreversible prodrugs require activation by an enzyme.
10. 10. Almond, H. R.; Manning, D. T.; Niemann, C. Biochemistry 1962, 1, 243.
11. 11. Aoshima, M.; Tsukagoshi, S.; Sakurai, Y.; Oh-ishi, J.; Ishida, T.; Kobayashi, H. Cancer Res. 1977, 37, 2481.
12. 12. Jung, M. E. Synlett 1990, 186.
13. 13. For the use of oxazolines in peptide synthesis, see: Wipf, P.; Heimgartner, H. Helv. Chim. Acta 1990, 73, 13 and ref cited therein.
14. 14. Use of an O-benzyl protective group on the glycolate residue led to partial saturation of the heterocyclic ring of the nucleotide during the hydrogenolytic benzyl ether cleavage.
15. 15. For reviews of peptide isosteres, see: (a) Spatola, A. F. Chem. Biochem. Amino Acids Pept. Proteins 1983, 7, 267;
16. (b) Giannis, A.; Kolter, T. Angew. Chem., Int. Ed. Engl. 1993, 32, 1244;
17. (c) Gante, J. Angew. Chem., Int. Ed. Engl. 1994, 33, 1699.
18. 16. (a) Gante, J. Synthesis 1989, 405;
19. (b) Gray, C. J.; Quibell, M.; Jiang, K.-L.; Baggett, N. Synthesis 1991, 141;
20. (c) Graybill, T. L.; Ross, M. J.; Gauvin, B. R.; Gregory, J. S.; Harris, A. L.; Ator, M. A.; Rinker, J. M.; Dolle, R. E. Bioorg. Med. Chem. Lett. 1992, 2, 1375.
21. 17. Niedrich, H.; Oehme, C.; Bergmann, J. J. Prakt. Chem. 1974, 316, 741.
22. 18. Li, W., M. S. Thesis, University of Pittsburgh, 1993.
23. 19. For the synthesis of lipid/peptide/drug conjugates of ara-C, see: Menger, F. M.; Guo, Y.; Lee, A. S. Bioconj. Chem. 1994, 5, 162.
24. 20. (a) Wyllie, A. H. Br. J. Cancer 1993, 67, 205;
25. (b) Thompson, C. B. Science 1995, 267, 1456.
26. 21. Harrison, D. J. J. Pathol. 1995, 175, 7.
27. 22. Kerr, J. F. R.; Wyllie, A. H.; Currie, A. R. Br. J. Cancer 1972, 26, 239.
28. 23. (a) Gorczyca, W.; Gong, J.; Ardelt, B.; Traganos, F.; Darzynkiewicz, Z. Cancer Res. 1993, 53, 3186;
29. (b) Grant, S.; Jarvis, W. D.; Swerdlow, P. S.; Turner, A. J.; Traylor, R. S.; Wallace, H. J.; Lin, P. S.; Pettit, G. R.; Gewirtz, D. A. Cancer Res. 1992, 52, 6270;
30. (c) Jarvis, W. D.; Povirk, L. F.; Turner, A. J.; Traylor, R. S.; Gewirtz, D. A.; Pettit, G. R.; Grant, S. Biochem. Pharmacol. 1994, 47, 839.
31. 24. Oberhammer, F.; Wilson, J. W.; Dive, C; Morris, I. D.; Hickman, J. A.; Wakeling, A. E.; Walker, P. R.; Sikorska, M. EMBO J. 1993, 12, 3679.
32. 25. Aristoff, P. A.; Johnson, P. D.; Sun, D.; Hurley, L. H. J. Med. Chem. 1993, 36, 1956.
33. 26. Ritke, M. K.; Rusnak, J. M.; Lazo, J. S.; Allan, W. P.; Dive, C.; Heer, S.; Yalowich, J. C. Mol. Pharmacol. 1994, 46, 605.